Peter Brodersen is a Professor at the Department of Biology, University of Copenhagen , specializing in Bioinformatics and RNA Biology . His research focuses on RNA modification (m6A), YTHDF proteins, and small RNA pathways in plants. Recent research trends from his group include: (1) molecular mechanisms of ARGONAUTE-small RNA interactions, (2) m6A-YTHDF regulatory systems in plant development, and (3) RNAi-independent roles of DICER-LIKE proteins in antiviral defense. Collaborations span Denmark and international institutions. Publications highlight cross-disciplinary work bridging computational biology and experimental plant genetics. Key subfields include RNA structure, epigenetic regulation, and antiviral immunity.
Jens S. Andersen is a Professor in the Department of Biochemistry and Molecular Biology at the University of Southern Denmark, where he leads research in Biomedical Mass Spectrometry and Systems Biology. His work is centered on the development and application of quantitative mass spectrometry and microscopy-based proteomics to study human cell biology, particularly the structure and function of organelles such as centrosomes, cilia, autophagosomes, and mitochondria. His research focuses on determining the protein composition and dynamic properties of cellular organelles, the roles of specific protein groups, and their contributions to biological processes and diseases. He investigates cell signaling mediated by post-translational modifications, especially within the DNA damage response, autophagy, and immune systems. His lab, the Jens S. Andersen Lab, is part of the Research Section of Biomedical Mass Spectrometry. The analysis of his recent publications reveals a strong interdisciplinary trend combining proteomics, structural biology, and cell signaling. His work spans cilia biology, RNA metabolism, DNA repair, and cancer mechanisms, with frequent use of advanced techniques like mass spectrometry, CRISPR, and live-cell imaging. The integration of systems biology approaches is evident across his research outputs. Professor, Department of Biochemistry and Molecular Biology, University of Southern Denmark Head of Research, Biomedical Mass Spectrometry and Systems Biology Principal Investigator, Jens S. Andersen Lab ORCID: 0000-0002-6091-140X While no specific scientific awards are mentioned in the provided texts, his extensive publication record in high-impact journals such as Science , Nature Communications , Molecular Cell , and EMBO Journal reflects significant scholarly contributions. He has supervised research projects and collaborated widely across Europe, though specific names of students are not listed. His research is supported by multiple ongoing projects, reflecting sustained funding and academic leadership. The Jens S. Andersen Lab operates at the intersection of proteomics and cell biology, contributing to fundamental understanding of organelle dynamics and disease mechanisms. The lab's work is highly collaborative, involving partnerships with groups in structural biology, RNA research, and cancer biology.
Kumar Somyajit is Associate Professor at the University of Southern Denmark's Department of Biochemistry and Molecular Biology. He leads research on DNA replication and genome surveillance mechanisms using mammalian cell models. Research focuses on: Metabolic regulation of DNA replication Replisome plasticity under stress Homology-directed repair mechanisms Chromatin dynamics in cancer Recipient of Lundbeck Foundation Fellowship (2021). Current projects investigate metabolic coupling to genome surveillance in cancer and development. Supervises PhD students in DNA repair and replication studies.
Jesper Velgaard Olsen is a Professor and Deputy Center Director at the University of Copenhagen's Novo Nordisk Foundation Center for Protein Research (CPR) and leads the Olsen Group. His research focuses on quantitative, high-resolution mass spectrometry-based proteomics, particularly in characterizing signaling networks regulated by phosphorylation and other post-translational modifications. The group develops advanced offline peptide fractionation and enrichment methods combined with high-resolution Orbitrap tandem mass spectrometry to improve robustness and reproducibility in proteomic analysis. The Olsen Group investigates functional selectivity in cell signaling, where different growth factors binding to the same receptor activate distinct pathways. They identified tyrosine phosphorylated residues as molecular switches determining cell fate and optimized workflows enabling deep human proteome analysis comparable to RNA-seq. Their work spans technology development and biological applications in diseases like acute myeloid leukemia. Key group members include PhD Fellows, PhD Students, and Researchers such as Agnete Witness Præst Jensen, Charlotte Hjort, and Kristina Bennet Emdal. For collaboration or inquiries, contact Olsen via email jesper.olsen@cpr.ku.dk .
Ole Nørregaard Jensen is a Professor in Biomedical Mass Spectrometry and Systems Biology at the Department of Biochemistry and Molecular Biology, University of Southern Denmark . His research integrates advanced mass spectrometry, proteomics, and bioinformatics to study chromatin biology, post-translational modifications, and cellular signaling networks. He is actively involved in major research initiatives funded by Novo Nordisk Foundation and Lundbeck Foundation. His research interests include Mass Spectrometry, Proteomics, Posttranslational Modification, Histone Biology, Chromatin Biology, Bioinformatics, Systems Biology, Lipidomics, and Protein Chemistry . He employs cutting-edge techniques such as tandem mass spectrometry and ion mobility spectrometry to analyze protein isomers and dynamic modifications. His work has significant implications for understanding gene regulation, DNA replication, and disease mechanisms. His recent publications demonstrate a strong trend in chromatin dynamics, epigenetics, and integrated omics approaches , combining proteomics with transcriptomics and lipidomics to unravel complex biological systems. His research spans from fundamental molecular mechanisms to translational applications in biomedicine and food science. He has been recognized with several prestigious awards: MCP Lectureship Award Juan Pablo Albar Proteomics Pioneer Award 2019 EliteForsk 2009 prize Knight Order of Dannebrog (Ridder af Dannebrogordenen) Jensen is deeply involved in academic service, including peer review for journals like Nature Communications and Molecular and Cellular Proteomics , organizing conferences, and supervising students. He teaches courses such as Biomedical Mass Spectrometry - Principles and Applications and coordinates the Computational Biomedicine international Master’s program. He leads multiple active research projects, including PLATO and INTEGRA, focusing on health data, imaging, and protein networks. He is a key member of a vibrant research environment in biomedical mass spectrometry at SDU, contributing to both national and international scientific collaborations. His lab is at the forefront of developing and applying novel mass spectrometry methodologies for systems biology.
Jamie Yam Auxillos is an Assistant Professor at the University of Copenhagen, affiliated with both the Biotech Research & Innovation Centre (BRIC) and the Department of Biology, where she leads research in Computational and RNA Biology. Her work bridges molecular biology, synthetic biology, and cutting-edge sequencing technologies. Education: PhD in Cell and Molecular Biology (2020), Centre for Systems and Synthetic Biology, University of Edinburgh MSc in Systems and Synthetic Biology (2015), University of Edinburgh BSc Honours in Biomedical Sciences with Medical Microbiology (2014), Newcastle University Dr. Auxillos' research focuses on Molecular Biology, Synthetic Biology, and Biotechnology , with particular expertise in Sequencing Methods Development, Spatial Transcriptomics, and Nanopore long read sequencing. Her work combines computational approaches with experimental techniques to develop new methods for RNA analysis and to understand complex biological systems, particularly in cancer biology and synthetic yeast engineering. Her recent publications reveal a strong trend toward developing innovative sequencing methodologies and applying them to cancer research, with significant contributions to spatial transcriptomics and tumor microenvironment analysis. She has also made important contributions to synthetic biology tools, particularly for yeast engineering and CRISPR-based technologies. Dr. Auxillos has established collaborative networks across multiple countries and institutions, with significant research output including journal articles, reviews, and book chapters that have garnered substantial attention across academic and social media platforms. Her research has been shared widely, with publications posted by numerous X (Twitter) users, featured on Facebook pages, discussed on Reddit, referenced in policy sources and patents, and read by hundreds of researchers on Mendeley.
Rafael Pinilla-Redondo is an Assistant Professor in the Department of Biology at the University of Copenhagen's Faculty of Science, where he leads the Bacterial Immunity research group within the Section of Microbiology. His laboratory, located at Universitetsparken 15 in Copenhagen, focuses on the molecular mechanisms of bacterial defense systems against phages. His research interests center on bacterial immunity, particularly how CRISPR-Cas and other bacterial immune systems evolve and function. He investigates the molecular mechanisms driving these complex systems to answer fundamental biological questions and develop novel biotechnologies. His work spans phage biology, molecular evolution, molecular biology, and genetics, with a specific emphasis on bacterial defense mechanisms against viral threats. Dr. Pinilla-Redondo's recent publications demonstrate significant contributions to understanding bacterial immune systems, particularly CRISPR-Cas variants, retrons, and other defense mechanisms. His research shows strong trends in structural biology approaches to understanding immune system function, with increasing focus on the supramolecular organization of defense complexes and their evolutionary implications. Villum Young Investigator grant (2023) His laboratory maintains active collaborations across multiple institutions, as evidenced by the international authorship on his publications. The lab has developed specialized software tools including CRISPR-Cas Typer for automated identification of CRISPR-Cas loci, Plasmid Network for exploring the global plasmidome, and Hoodini (coming soon) for genome neighborhood visualization. His work has received significant attention, with multiple papers picked up by news outlets, blogged about, and widely shared on social media platforms. The Pinilla-Redondo Lab is part of the vibrant microbiology research community at the University of Copenhagen, focusing on the evolutionary arms race between bacteria and their viral predators.
Joseph Matthew Rogers is an Associate Professor in the Department of Drug Design and Pharmacology at the Faculty of Health and Medical Sciences, University of Copenhagen. His research focuses on innovative approaches to drug discovery and protein engineering with particular emphasis on peptide-based therapeutics. His research interests include: De novo protein and peptide design mRNA display technology for drug discovery GPCR-targeted therapeutics Computational approaches to protein engineering Development of peptide-based inhibitors Structural biology of protein-peptide interactions Dr. Rogers' recent publications demonstrate a strong focus on applying advanced biotechnological approaches to address challenging problems in pharmacology. His work spans from designing miniprotein modulators for stroke treatment to engineering novel protein binders and cyclic peptide inhibitors. He has published in high-impact journals including Nature, Journal of the American Chemical Society, and Angewandte Chemie. His research has received significant attention with publications being picked up by 18 news outlets, blogged about by multiple sources, and referenced by numerous social media users. His work has also been incorporated into clinical guideline sources, demonstrating its translational impact and relevance to medical practice. Dr. Rogers maintains an active research program with 29 total research outputs including journal articles, conference abstracts, reviews, and book chapters. His work bridges the gap between basic science and therapeutic applications, with particular focus on neurological conditions and innovative drug modalities.
Birgitte H. Kallipolitis is a Professor in Molecular Microbiology at the Department of Biochemistry and Molecular Biology, University of Southern Denmark. She has held academic positions at the institution since 2001, progressing from Assistant Professor to full Professor in 2017. Her research is centered on gene regulatory mechanisms in Gram-positive pathogens, particularly Listeria monocytogenes and Staphylococcus aureus . Ph.D. : Molecular Biology, University of Southern Denmark, 1997 Postdoctoral Fellow : University of Copenhagen Visiting Scientist : University College Cork, Ireland Her research interests lie at the intersection of molecular microbiology and gene regulation. She investigates how small regulatory RNAs (sRNAs), two-component systems, and environmental signals such as fatty acids control bacterial virulence, stress responses, and antibiotic resistance. Her work provides critical insights into the molecular mechanisms that enable pathogens to survive in hostile environments and cause disease. Using advanced molecular and biochemical techniques, her group studies RNA-protein and RNA-RNA interactions, transcriptional regulation, and post-transcriptional control in bacterial systems. The publication trends over the last five years reflect a strong focus on Listeria monocytogenes virulence regulation by fatty acids and sRNAs, stress response systems like LisRK, and the role of surface proteins in Staphylococcus aureus biofilms. Her recent work also includes methodological contributions in RNA analysis and genomic epidemiology of resistant pathogens. The keywords across her articles highlight consistent themes in RNA biology , gene regulation , infection mechanisms , and antimicrobial strategies . Scientific Awards: Prize (1 mentioned in profile) Professor Kallipolitis has supervised several Ph.D. and Master’s students, including E. M. S. Lillebæk, P. T. Dos Santos, and M. Thorsing, and has been involved in numerous research projects funded by national and international grants. Her work has significant implications for understanding bacterial pathogenesis and developing novel anti-infective strategies. She leads the Molecular Microbiology research section and manages a biosafety level 2 laboratory equipped for infection studies using C. elegans and cultured mammalian cells. Research Group: The Kallipolitis Lab, also known as the Molecular Microbiology group, focuses on RNA and protein-based regulatory systems in Gram-positive bacteria. The lab maintains facilities for molecular cloning, gene expression analysis, protein purification, and infection assays, contributing to a comprehensive understanding of bacterial gene regulation and host-pathogen interactions.
Jesper Wengel serves as the Dean of the Faculty of Engineering and Science at Aalborg University (AAU), Denmark, where he leads academic and research initiatives. As a prominent researcher, his work has significantly advanced Oligonucleotide Biochemistry and Locked Nucleic Acid applications in therapeutic contexts. Role: Dean, Faculty of Engineering and Science, AAU (since December 1, 2024) Previous Affiliation: Pro-Dean for Innovation and Society at the University of Copenhagen His research focuses on Biochemistry , Genetics , and Molecular Biology , with emphasis on: DNA/RNA chemistry and modifications Therapeutic oligonucleotide design Biomolecular assembly and drug delivery systems Anti-gene clamps targeting neurodegenerative diseases Peptide-oligonucleotide conjugates Thiol conjugation techniques Recent publications highlight his expertise in Bioconjugate Chemistry and Nucleic Acid Therapeutics , particularly in: Modular albumin-Holliday junction systems for prolonged circulation Anti-gene oligonucleotide clamps for Huntington's disease Improved thiol conjugation for biomolecular stability He has also contributed to patent development in oligonucleotide-based therapeutics, though specific scientific awards are not detailed in the provided text.
Jörg P. Kutter is a Professor in the Department of Pharmacy at the University of Copenhagen, where he leads the Microscale Analytical Systems research group. His work focuses on the design and development of lab-on-a-chip devices and microfluidic systems for analytical applications across biomedical, pharmaceutical, environmental and industrial fields. Professor Kutter's research expertise spans multiple areas of microfluidics and analytical chemistry. He specializes in chemical separation techniques including chromatography and electrophoresis, as well as FIA-based systems and integration of optical detection elements. His current work emphasizes microfabricated lab-on-a-chip systems with focus on separation and sample preparation techniques, and advanced micro and nano liquid handling. His research group has developed numerous applications using thiol-ene based microfluidic platforms, which have become a signature technology in his laboratory. Analysis of Professor Kutter's recent publications (2022-2024) reveals a strong progression from fundamental microfluidic techniques toward increasingly complex biological applications. His work now prominently features DNA analysis (particularly extrachromosomal circular DNA), olfactory mucus analysis using humanized yeast biosensors, pulmonary delivery of siRNA-loaded nanoparticles, glycopeptide enrichment for inflammation-related protein analysis, and microfluidic steroidogenesis assays. This evolution demonstrates the maturation of microfluidics technology and its growing impact on biomedical research and clinical diagnostics. Professor Kutter has secured several millions of Euros in funding support for national and international (EU) projects. He served as coordinator for a European STREP project (2007-2010) with seven partners and a European IP (2010-2015) with 16 partners. He has supervised 14 post-doctoral fellows, 20 PhD students, and 12 master's theses, demonstrating a strong commitment to academic mentoring and research training. He serves as Deputy editor for Electrophoresis and is a member of the Board of Directors of the Chemical and Biological Microsystems Society. He participates in technical program committees for major conferences including µ-TAS, MEMS, MSB and Transducers. Additionally, he acts as a scientific advisor for the Institute for Microtechnology in Mainz, Germany, and evaluates proposals for national and international funding agencies as well as educational accrediting agencies.
Nicolas Julien Fossat serves as an Associate Professor in the Department of Immunology and Microbiology at the Faculty of Health and Medical Sciences, University of Copenhagen. His research spans virology, RNA biology, and developmental biology with a particular focus on viral-host interactions and molecular mechanisms of disease. His research interests primarily focus on RNA biology and virology, with significant contributions to understanding viral RNA modifications, microRNA interactions in viral infections, and the molecular mechanisms of viral replication. His work on Hepatitis C virus RNA capping with flavin adenine dinucleotide represents a major discovery in the field of virology. Additionally, his research extends to developmental biology, particularly in understanding transcription factor networks like TWIST1 in cell differentiation processes. Analysis of his recent publications reveals a strong emphasis on RNA-virus interactions, particularly with flaviviruses including Hepatitis C, yellow fever, and tick-borne encephalitis viruses. His work on SARS-CoV-2 microRNA interactomes during the pandemic demonstrates his ability to pivot research toward emerging health threats. His publications in high-impact journals including Nature, Nature Communications, and Cell Reports highlight the significance of his contributions to the field. Fossat has established productive collaborations with prominent researchers including Bukh, Scheel, and Ramirez, resulting in multiple high-impact publications. His work has received substantial attention, with several papers being highlighted in news outlets and social media platforms, indicating the broader impact of his research.
Anja Groth, 43 years old, is a full professor at the Biotech Research and Innovation Centre (BRIC) under the University of Copenhagen's Faculty of Health Sciences. Her research centers on molecular cell biology, epigenetics, DNA repair, and genome stability, with significant contributions to understanding how cells maintain functional memory during division—a critical process for both human development and cancer progression. Education: MSc in Biochemistry, University of Copenhagen PhD in Cancer Biology, University of Copenhagen (2004) Postdoc at Institut Curie, Paris (3 years) Her groundbreaking work on DNA repair mechanisms revealed a protein critical for cancer cell survival through error-free DNA repair. This discovery is paving the way for novel cancer therapies that block this protein. Using advanced molecular biology and interdisciplinary collaboration, she has published in top journals like Nature and secured two major ERC grants. Key Research Themes: Epigenetic memory and chromatin replication DNA damage repair pathways Histone dynamics and inheritance Replication fork stability Protein networks in genome maintenance Articles show a consistent focus on histone chaperones, ubiquitination pathways, and chromatin assembly factors. Her 2016 discovery of H4K20me0 marks and the TONSL–MMS22L complex has had lasting impacts on DNA repair research. Awards & Grants: EliteForsk Award (2018) EMBO Investigator Heirloom Award for Women Scientist Leaders ERC Starting Grant ERC Consolidator Grant As leader of a diverse research group of 15 international scientists (primarily women), Groth emphasizes collaborative innovation and trust-building in scientific environments. She advocates for sustainable lab practices and flexible research strategies that allow unexpected discoveries.
Irina Kratchmarova is an Associate Professor at the Department of Biochemistry and Molecular Biology , University of Southern Denmark , specializing in Biomedical Mass Spectrometry and Systems Biology . Her research integrates quantitative proteomics and systems biology to investigate protein secretion in muscle and adipose tissues, post-translational modifications, and their roles in metabolic and inflammatory diseases. Phosphoproteomics and signaling networks Secretome analysis in muscle and fat Protein family interactions in cancer and reproduction Stable isotope labeling and mass spectrometry Key projects include collaborations with the Ministry of Education and Research (FSS) and foundations like Novo Nordisk and Lundbeck to study dysferlinopathies and muscle/adipose crosstalk. She has presented at institutions such as Freiburg Institute for Advanced Studies .
Simon Toftholm Jakobsen is a Postdoctoral Researcher in the Department of Biochemistry and Molecular Biology at the University of Southern Denmark, specializing in Functional Genomic Studies and Metabolism. His research focuses on epigenetic mechanisms and transcriptional regulation with significant implications for cancer biology. Dr. Jakobsen's research spans several interconnected domains: Epigenetic regulation of gene expression Transcriptional enhancer and promoter dynamics MYC oncogene function in cancer progression DNA methylation and demethylation processes Single-cell resolution of transcriptional regulation Carcinogenesis mechanisms His recent publications demonstrate a strong focus on how epigenetic mechanisms influence cancer development, particularly examining MYC's role in regulating transcription through enhancer regions and how epigenetic modifications affect cancer cell behavior. His work bridges fundamental molecular mechanisms with potential therapeutic applications in oncology. Dr. Jakobsen is actively involved in research funding, currently participating in the project 'Transcriptional regulation at single-cell resolution' (2022-2027), which investigates enhancer regions, epigenetics, transcription, and demethylation using advanced single-cell approaches. His research has received significant attention, with multiple media features in March 2024 highlighting new insights into cancer cell growth and spread, suggesting potential targets for future cancer treatments.
